Friday Blog Roundup

The FDA bill wasnât the only thing getting health policy types excited this week. Senator Clinton unveiled her healthcare proposal, and provided fodder for bloggers, including: Ezra Klein (here, too) GoozNews, the Numbers Guy, RH Reality Check, and WSJ Health Blog.

Also focusing on the executive branch, Tom Philpott at Gristmill reports on Chuck Connor, whoâs played key role in advancing the interests of ADM and other members of the Corn Refiners Association â and whoâs now the acting secretary at USDA.

Elsewhere:

Roy M. Poses MD at Health Care Renewal explains whoâs behind a recent report on U.S. hospital quality, and how the Leapfrog Groupâs membership might bias the report.

Lynn Harris at Broadsheet examines a new report that finds women of childbearing age arenât getting enough counseling about the risks of birth defects associated with certain drugs.

Ed Silverman at Pharmalot points out that the FDA isnât alone in needing drug-safety reform â the UKâs Medicines and Healthcare products Regulatory Agency is also criticized for failing to monitor drugs on the market adequately.

Cervantes at Stayinâ Alive warns of impending public health emergencies, as identified by the World Health Organization.

Tara C. Smith at Aetiology and Abel Pharmboy at Terra Sigillata consider the bleak prospects for young biomedical researchers competing for too few jobs.

The Olive Ridley Crawl highlights yet another reason why coal is evil.

Amanda at Enviroblog reports on a new study about dust and PBDEs (and gets a Queen song stuck in her readersâ heads).

More like this

Bloggers are bringing us lots of drug news this week: Abel Pharmboy at Terra Sigillata explains why a decision by the Centers for Medicare and Medicaid Services is devastating news for lymphoma patients â and possibly for all cancer patients (here, too). Ed Silverman at Pharmalot considers the…
In recognition of the second anniversary of Hurricane Katrina, Chris Mooney and Sheril Kirshenbaum at The Intersection provide a series of posts about the lessons from this disaster. At Gristmill, Joseph Romm explains why Hurricane Katrina busts the myth that humans can adapt to climate change.…
What's new at the FDA? Ed Silverman at Pharmalot reports on FDA plans to spend some of its user-fee money on post-marketing safety activities. Merrill Goozner at GoozNews warns that the FDA is scrapping the Helsinki Declaration on protecting human subjects. Jacob Goldstein at WSJ's Health Blog…
This week, bloggers had plenty to say regarding the new study raising safety questions about the diabetes drug Avandia. The Olive Ridley Crawl and Merrill Goozner at GoozNews emphasize the importance of transparency around clinical trials, while Cervantes at Stayinâ Alive explains whatâs wrong with…